mifepristone has been researched along with Body Weight in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (7.58) | 18.7374 |
| 1990's | 26 (39.39) | 18.2507 |
| 2000's | 16 (24.24) | 29.6817 |
| 2010's | 19 (28.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bethea, JR; Jiang, J; Norden, DM | 1 |
| Berry, JN; Butler, TR; Prendergast, MA; Reynolds, AR; Sharrett-Field, L | 1 |
| Breivik, T; Gjermo, P; Gundersen, Y; Opstad, PK | 1 |
| Kagami, K; Nishigori, H | 1 |
| Anton, F; Hanesch, U; Le Coz, GM | 1 |
| Beaudry, JL; Belanoff, JK; Dunford, EC; Hunt, H; Riddell, MC; Teich, T; Zaharieva, D | 1 |
| Chijiwa, T; Lkhagvasuren, B; Oka, T; Sudo, N; Yoshihara, K | 1 |
| Belanoff, JK; Boon, MR; Hunt, H; Meijer, OC; Pereira, AM; Peschier-van der Put, E; Rensen, PC; van Beek, L; van den Heuvel, JK; van Dijk, KW; van Harmelen, V; van Hengel, I | 1 |
| Beaudry, JL; Belanoff, JK; Dunford, EC; Hunt, H; Pivovarov, JA; Porras, DP; Riddell, MC; Teich, T | 1 |
| Bechtold, AG; Hochhaus, G; Patel, G; Scheuer, DA | 1 |
| Flatt, PR; Frizzell, N; Gault, VA; McKillop, AM; Taylor, AI | 1 |
| Chen, H; Chen, Z; Dai, W; Guan, M; Lane, NE; Pham, A; Shahnazari, M; Yao, W | 1 |
| Cano, R; Cejas, H; Correa, SG; Porporatto, C; Rodríguez-Galán, MC; Sotomayor, CE | 1 |
| Biller, BM; Findling, JW; Fleseriu, M; Gross, C; Molitch, ME; Schteingart, DE | 1 |
| Kmiec, Z; Stelmanska, E; Swierczynski, J | 1 |
| Bradley, AJ; Feay, N; Geiser, F; McAllan, BM | 1 |
| Belanoff, JK; Champagne, DL; Claessens, SE; de Kloet, ER; Kanatsou, S; Lucassen, PJ | 1 |
| Hu, P; Joëls, M; Lucassen, PJ; Oomen, C; van Dam, AM; Wester, J; Zhou, JN | 1 |
| Hong, L; Schmidt, T; Stanford, C; Wei, N; Yu, Y | 1 |
| Sutton, RL; Taylor, AN; Tio, DL | 1 |
| Hsieh, TH; Kuo, YM; Lin, CH; Lin, YC; Lin, YJ; Sze, CI | 1 |
| Arias, J; Artaza, J; Bhasin, S; Gonzalez-Cadavid, N; Ma, K; Mahabadi, V; Mallidis, C; Salehian, B | 1 |
| Archambault, EZ; Boatright, NK; Fray, J; Hicks, E; Kirchain, S; McCune, SA; Sharkey, LC; Simpson, GI | 1 |
| Mondry, A | 1 |
| Barja-Fidalgo, TC; Barreto, EO; Bertho, AL; Carvalho, VF; Cordeiro, RS; e Silva, PM; Martins, MA; Oliveira, MS | 1 |
| Beebe, KL; Belanoff, JK; Blasey, C; Block, T; Debattista, C | 1 |
| Kadotomi, Y; Kang, Z; Li, X; Song, C | 1 |
| Joëls, M; van Gemert, NG | 1 |
| Glavas, MM; Weinberg, J; Yu, WK | 1 |
| Joëls, M; Karst, H | 1 |
| Bruch, D; Harb, G; Kieffer, TJ; Korbutt, GS; Lam, AW; Lam, NT; Oosman, SN; Unniappan, S; Webber, T; Zhang, QX | 1 |
| Baer, DJ; Castonguay, TW; Trocki, O | 1 |
| Challet, E; Cherel, Y; le Maho, Y; Malan, A; Robin, JP | 1 |
| Bardin, CW; Kaplan-Kraicer, R; Shalgi, R | 1 |
| Engel, JA; Eriksson, CJ; Fahlke, C; Hansen, S; Hård, E | 1 |
| Brandt, HA; Chrousos, GP; DeBellis, MD; Demitrack, MA; Gold, PW; Kalogeras, KT; Kling, MA; Listwak, SJ; Whitfield, HJ | 1 |
| Borysewicz, R; Fu, CL; Lee, PC; Werlin, SL | 1 |
| Duncan, GS; Flower, RJ; Peers, SH | 1 |
| Baram, TZ; Masters, JN; Yi, SJ | 1 |
| Heikinheimo, O; Spitz, IM; Wade, CE | 1 |
| Hunt, A; Kelly, FJ; Langley, SC; Postle, AD; Rickett, GW; York, DA | 1 |
| Bell, SC; Sadek, S | 1 |
| Dagnault, A; Deshaies, Y; Richard, D | 1 |
| Busch, BL; Curry, DL; Dallman, MF; Havel, PJ; Johnson, PR; Stern, JS | 1 |
| Nedvídková, J; Schreiber, V; Stárka, L | 1 |
| Bertagna, X | 1 |
| Burns, SJ; Dryden, S; Frankish, HM; Williams, G | 1 |
| Daly, JM; Evoy, D; Fujita, J; Mackrell, P; McCarter, MD; Naama, HA; Rivadeneira, DE | 1 |
| Flynn, NE; Knabe, DA; Wu, G | 1 |
| Aldaghlas, TA; Holleran, AL; Kelleher, JK; Lindenthal, B; Ruan, B; Schroepfer, GJ; Wilson, WK | 1 |
| Buntin, JD; Koch, KA; Wingfield, JC | 1 |
| Cao, T; O'Malley, BW; Roop, DR; Tsai, SY; Wang, XJ | 1 |
| Kalimi, M; Opoku, J | 1 |
| Abe, T; Chambers, TJ; Chow, JW; Lean, JM | 1 |
| Barfield, RJ; Pleim, ET; Weinstein, MA | 1 |
| Baumgarten, R; van der Schoot, P | 1 |
| Breban, M; Fournier, C; Gougerot-Pocidalo, MA; Muffat-Joly, M; Pocidalo, JJ | 1 |
| Muskiet, FA; Slappendel, EJ; van der Schoot, P; Zeegers, TA | 1 |
| Dubuc, PU; Peterson, CM | 1 |
| Slappendel, EJ; Uilenbroek, JT; van der Schoot, P | 1 |
| Langley, SC; York, DA | 1 |
| Kalimi, M | 1 |
| Bardin, CW; Heikinheimo, O; Krieger, DT; Lahteenmaki, P; Spitz, IM; Wade, CE | 1 |
| Bons, EG; Lamberts, SW; Uitterlinden, P; Verleun, T | 1 |
| Bakker, GH; de Jong, FH; Henkelman, MS; Klijn, JG; Lamberts, SW; Setyono-Han, B; van der Schoot, P | 1 |
| Konagaya, M; Max, SR | 1 |
3 trial(s) available for mifepristone and Body Weight
| Article | Year |
|---|---|
Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Composition; Body Weight; Cushing Syndrome; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Hormone Antagonists; Humans; Hydrocortisone; Hypertension; Male; Middle Aged; Mifepristone; Quality of Life; Quinolines; Receptors, Glucocorticoid; Urea | 2012 |
Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients.
Topics: Adrenocorticotropic Hormone; Adult; Anorexia Nervosa; Body Weight; Double-Blind Method; Female; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mifepristone; Pituitary-Adrenal System; Psychiatric Status Rating Scales | 1993 |
Pituitary-adrenal response to RU 486 in man.
Topics: Blood Pressure; Body Temperature; Body Weight; Cross-Over Studies; Double-Blind Method; Heart Rate; Hormone Antagonists; Humans; Hydrocortisone; Male; Mifepristone; Pituitary-Adrenal System | 1997 |
63 other study(ies) available for mifepristone and Body Weight
| Article | Year |
|---|---|
Impaired CD8 T cell antiviral immunity following acute spinal cord injury.
Topics: Acute Disease; Animals; Antiviral Agents; Body Weight; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Flow Cytometry; Hemagglutinin Glycoproteins, Influenza Virus; Hormone Antagonists; Inflammation; Lung; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Orthomyxoviridae Infections; Spinal Cord Injuries; Spleen | 2018 |
Mifepristone pretreatment reduces ethanol withdrawal severity in vivo.
Topics: Alcoholism; Animals; Body Weight; Corticosterone; Drug Evaluation, Preclinical; Eating; Ethanol; Hormone Antagonists; Male; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Severity of Illness Index; Substance Withdrawal Syndrome | 2013 |
Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis.
Topics: Alveolar Bone Loss; Animals; Blood Glucose; Body Weight; Corticosterone; Diabetes Mellitus, Experimental; Drug Implants; Escherichia coli; Hormone Antagonists; Hypothalamo-Hypophyseal System; Interleukin-10; Lipopolysaccharides; Mifepristone; Periodontitis; Pituitary-Adrenal System; Placebos; Radiography; Random Allocation; Rats; Receptors, Glucocorticoid; Streptozocin; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2014 |
Impaired imprinting and social behaviors in chicks exposed to mifepristone, a glucocorticoid receptor antagonist, during the final week of embryogenesis.
Topics: Aggression; Animals; Body Weight; Brain; Chick Embryo; Female; Imprinting, Psychological; Learning Disabilities; Mifepristone; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Glucocorticoid; Social Behavior Disorders; Vocalization, Animal | 2014 |
Glucocorticoid-mediated enhancement of glutamatergic transmission may outweigh anti-inflammatory effects under conditions of neuropathic pain.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cytokines; Disease Models, Animal; Gene Expression; Glucocorticoids; Glutamic Acid; Male; Mifepristone; Neuralgia; Pain Threshold; Peripheral Nerve Injuries; Rats; Receptors, Glucocorticoid; Synaptic Transmission | 2014 |
Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats.
Topics: Animals; Blood Glucose; Body Weight; Corticosterone; Diabetes Mellitus, Experimental; Diet, High-Fat; Hormone Antagonists; Insulin; Insulin Resistance; Male; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Small Molecule Libraries | 2014 |
Prior chronic stress induces persistent polyI:C-induced allodynia and depressive-like behavior in rats: Possible involvement of glucocorticoids and microglia.
Topics: Animals; Body Weight; Depression; Disease Models, Animal; Drug Administration Routes; Eating; Fever; Hormone Antagonists; Hyperalgesia; Interferon Inducers; Male; Mifepristone; Minocycline; Pain Management; Poly I-C; Rats; Rats, Long-Evans; Rats, Wistar; Stress, Psychological; Swimming; Time Factors | 2015 |
Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation.
Topics: Animals; Body Weight; Diet, High-Fat; Inflammation; Male; Mice; Mice, Inbred C57BL; Mifepristone; Obesity; RAW 264.7 Cells; Receptors, Glucocorticoid | 2016 |
Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiposity; Animals; Blood Glucose; Blotting, Western; Body Weight; Caloric Restriction; Gluconeogenesis; Glucose Intolerance; Glucose Tolerance Test; Glycogen; Glycogenolysis; Hormone Antagonists; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipolysis; Liver; Male; Mifepristone; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2016 |
Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress.
Topics: Adaptation, Physiological; Animals; Blood Pressure; Body Weight; Corticosterone; Disease Models, Animal; Heart Rate; Hormone Antagonists; Hypertension; Male; Mifepristone; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Rhombencephalon; Stress, Physiological | 2009 |
Effect of RU486 on hepatic and adipocyte gene expression improves diabetes control in obesity-type 2 diabetes.
Topics: Adipocytes; Adipose Tissue, White; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Epididymis; Fasting; Feeding Behavior; Gene Expression Regulation; Glucose Tolerance Test; Insulin; Liver; Male; Mice; Mice, Obese; Mifepristone; Obesity; Pancreas; RNA, Messenger; Triglycerides | 2009 |
Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.
Topics: Animals; Apoptosis; Body Weight; Bone Density; Bone Development; Bone Resorption; Cell Differentiation; Cells, Cultured; Female; Hormone Antagonists; Male; Mice; Mice, Knockout; Mifepristone; Osteoblasts; Osteogenesis; Receptors, Progesterone; Sex Factors | 2010 |
Immune-metabolic balance in stressed rats during Candida albicans infection.
Topics: Animals; Blood Glucose; Body Weight; Candidiasis; Eating; Female; Food Deprivation; Glucocorticoids; Hormone Antagonists; Leptin; Liver; Liver Glycogen; Mifepristone; Rats; Rats, Wistar; Stress, Psychological; Tumor Necrosis Factor-alpha | 2010 |
The gender- and fat depot-specific regulation of leptin, resistin and adiponectin genes expression by progesterone in rat.
Topics: Adiponectin; Adipose Tissue, White; Animals; Body Weight; Female; Gene Expression Regulation; Hormone Antagonists; Leptin; Male; Mifepristone; Progesterone; Rats; Receptors, Progesterone; Resistin; RNA, Messenger; Sex Characteristics | 2012 |
The influence of reproductive hormones on the torpor patterns of the marsupial Sminthopsis macroura: bet-hedging in an unpredictable environment.
Topics: Adaptation, Physiological; Animals; Basal Metabolism; Body Temperature; Body Temperature Regulation; Body Weight; Circadian Rhythm; Estrogens; Female; Flutamide; Hormone Antagonists; Male; Marsupialia; Mifepristone; Photoperiod; Progesterone; Reproduction; Tamoxifen; Testosterone | 2012 |
Acute effects of neonatal dexamethasone treatment on proliferation and astrocyte immunoreactivity in hippocampus and corpus callosum: towards a rescue strategy.
Topics: Age Factors; Animals; Animals, Newborn; Astrocytes; Body Weight; Cell Count; Cell Proliferation; Corpus Callosum; Dexamethasone; Drug Administration Routes; Glial Fibrillary Acidic Protein; Glucocorticoids; Hippocampus; Hormone Antagonists; Ki-67 Antigen; Mifepristone; Rats; Rats, Long-Evans | 2012 |
A single-day treatment with mifepristone is sufficient to normalize chronic glucocorticoid induced suppression of hippocampal cell proliferation.
Topics: Animals; Body Weight; Cell Proliferation; Corticosterone; Dentate Gyrus; Doublecortin Protein; Glucocorticoids; Hippocampus; Immunohistochemistry; Male; Mifepristone; Rats; Rats, Wistar | 2012 |
Effects of glucocorticoid receptor antagonist, RU486, on the proliferative and differentiation capabilities of bone marrow mesenchymal stromal cells in ovariectomized rats.
Topics: Animals; Body Weight; Cell Differentiation; Cell Proliferation; Corticosterone; Estrogens; Female; Hormone Antagonists; Mesenchymal Stem Cells; Mifepristone; Models, Animal; Ovariectomy; Oxidative Stress; Phenols; Plant Extracts; Rats; Rats, Inbred F344; Receptors, Glucocorticoid; Superoxide Dismutase | 2013 |
Restoration of neuroendocrine stress response by glucocorticoid receptor or GABA(A) receptor antagonists after experimental traumatic brain injury.
Topics: Amygdala; Analysis of Variance; Animals; Bicuculline; Body Weight; Brain Injuries; Cell Count; Corticosterone; Functional Laterality; GABA-A Receptor Antagonists; Glutamate Decarboxylase; Hippocampus; Hypothalamo-Hypophyseal System; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Mifepristone; Neurosecretory Systems; Parvalbumins; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Stress, Physiological | 2013 |
The role of glucocorticoid receptors in dexamethasone-induced apoptosis of neuroprogenitor cells in the hippocampus of rat pups.
Topics: Animals; Apoptosis; Blotting, Western; Body Weight; Brain; Dexamethasone; Female; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Mifepristone; Neural Stem Cells; Organ Size; Pregnancy; Rats; Rats, Wistar; Receptors, Glucocorticoid | 2013 |
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression.
Topics: Animals; Body Weight; Dexamethasone; Gene Expression Regulation; Glucocorticoids; Kinetics; Male; Mifepristone; Muscle, Skeletal; Muscular Atrophy; Myostatin; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; RNA, Messenger; Transforming Growth Factor beta | 2003 |
Progesterone increases blood pressure in spontaneous gestational hypertension in rats.
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Body Weight; Creatinine; Disease Models, Animal; Estrogens; Female; Hypertension, Pregnancy-Induced; Kidney; Male; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Systole | 2005 |
Antiglucocorticoid RU38486 reduces net protein catabolism in experimental acute renal failure.
Topics: Acidosis; Acute Kidney Injury; Amino Acids; Animals; Body Weight; Chromatography, High Pressure Liquid; Glucocorticoids; Hormone Antagonists; Male; Methylhistidines; Mifepristone; Muscle Proteins; Nephrectomy; Oxygen Consumption; Rats; Rats, Wistar; Uremia | 2005 |
High levels of filamentous actin and apoptosis correlate with mast cell refractoriness under alloxan-evoked diabetes.
Topics: Abortifacient Agents; Actins; Adrenalectomy; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Blotting, Western; Body Weight; Cell Separation; Depsipeptides; Diabetes Mellitus, Experimental; Flow Cytometry; Glucocorticoids; Histamine Release; Male; Mast Cells; Microscopy, Fluorescence; Mifepristone; Prostaglandin D2; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 2006 |
The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
Topics: Abdominal Fat; Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Female; Hormone Antagonists; Mifepristone; Olanzapine; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Progesterone; Weight Gain | 2006 |
Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Weight; Corticosterone; Dinoprostone; Dopamine; Drug Interactions; Eicosapentaenoic Acid; Homovanillic Acid; Hormone Antagonists; Interleukin-1beta; Male; Mifepristone; Nucleus Accumbens; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley | 2007 |
Effect of chronic stress and mifepristone treatment on voltage-dependent Ca2+ currents in rat hippocampal dentate gyrus.
Topics: Animals; Body Weight; Calcium Channels, L-Type; Chronic Disease; Cold Temperature; Corticosterone; Crowding; Dentate Gyrus; Hormone Antagonists; Immobilization; In Vitro Techniques; Male; Membrane Potentials; Mifepristone; Milk; Organ Size; Patch-Clamp Techniques; Rats; Rats, Wistar; RNA, Messenger; Social Isolation; Stress, Psychological; Swimming | 2006 |
Effects of mineralocorticoid and glucocorticoid receptor blockade on hypothalamic-pituitary-adrenal function in female rats prenatally exposed to ethanol.
Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Central Nervous System Depressants; Ethanol; Feedback; Female; Hormone Antagonists; Hydrocortisone; Hypothalamo-Hypophyseal System; Lactation; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Restraint, Physical; Spironolactone; Stress, Psychological | 2006 |
Brief RU 38486 treatment normalizes the effects of chronic stress on calcium currents in rat hippocampal CA1 neurons.
Topics: Animals; Body Weight; Calcium; Corticosterone; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Hippocampus; Hormone Antagonists; In Vitro Techniques; Male; Membrane Potentials; Mifepristone; Neurons; Patch-Clamp Techniques; Rats; Rats, Wistar; Stress, Physiological | 2007 |
Treatment of obesity and diabetes in mice by transplant of gut cells engineered to produce leptin.
Topics: Adipose Tissue; Animals; Body Weight; Cell Transplantation; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Insulin; Kidney; Leptin; Mice; Mice, Obese; Mifepristone; Obesity; RNA, Messenger; Transfection | 2008 |
Comparison of effects of adrenalectomy and RU-486 in rats given a choice of maintenance diet and fat supplement.
Topics: Adrenalectomy; Animals; Body Composition; Body Weight; Corticosterone; Diet; Dietary Fats; Eating; Energy Intake; Food Preferences; Glucose Intolerance; Insulin; Male; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Triglycerides | 1995 |
Involvement of corticosterone in the fasting-induced rise in protein utilization and locomotor activity.
Topics: Adipose Tissue; Adrenal Glands; Animals; Body Weight; Circadian Rhythm; Corticosterone; Epididymis; Fasting; Male; Mifepristone; Motor Activity; Nitrogen; Proteins; Rats; Rats, Sprague-Dawley; Running | 1995 |
Anordiol and RU486 synergize to produce preimplantation pregnancy loss by increasing embryo transport (rat).
Topics: Abortion, Induced; Animals; Body Weight; Drug Synergism; Embryonic Development; Female; Fetus; Mifepristone; Norandrostanes; Ovum Transport; Pregnancy; Rats; Rats, Wistar | 1995 |
Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists.
Topics: Adrenalectomy; Alcohol Drinking; Animals; Body Weight; Corticosterone; Dexamethasone; Drinking; Drug Implants; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Organ Size; Rats; Rats, Wistar; Receptors, Steroid; Sodium Chloride; Spironolactone | 1995 |
Thyroidal regulation of lingual lipase development in suckling rats.
Topics: Animals; Animals, Suckling; Body Weight; Dose-Response Relationship, Drug; Hypothyroidism; Lipase; Mifepristone; Pancreas; Propylthiouracil; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Thyroid Gland; Thyroxine; Tongue | 1993 |
Development of specific antibody and in vivo response to antigen in different rat strains: effect of dexamethasone and importance of endogenous corticosteroids.
Topics: Adrenal Cortex Hormones; Animals; Antibody Specificity; Body Weight; Dexamethasone; Edema; Female; Freund's Adjuvant; Immunoglobulin E; Immunoglobulin G; Male; Mifepristone; Ovalbumin; Rats; Rats, Inbred BN; Rats, Inbred F344; Rats, Inbred Strains; Rats, Wistar; Species Specificity | 1993 |
Effects of a specific glucocorticoid receptor antagonist on corticotropin releasing hormone gene expression in the paraventricular nucleus of the neonatal rat.
Topics: Animals; Animals, Newborn; Body Weight; Cholesterol; Corticotropin-Releasing Hormone; Cortisone; DNA Probes; Drug Implants; Female; Gene Expression; In Situ Hybridization; Male; Mifepristone; Paraventricular Hypothalamic Nucleus; Pregnancy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; RNA, Messenger; Stress, Physiological; Up-Regulation | 1993 |
The divergent effect of RU 486 on adrenal function in the dog is related to differences in its pharmacokinetics.
Topics: Administration, Oral; Adrenal Cortex; Adrenocorticotropic Hormone; Analysis of Variance; Animals; Blood Proteins; Body Weight; Dogs; Female; Hydrocortisone; Hypoglycemia; Hypothalamo-Hypophyseal System; Insulin; Metyrapone; Mifepristone; Pituitary-Adrenal System; Time Factors | 1993 |
Effects of the glucocorticoid agonist, RU28362, and the antagonist RU486 on lung phosphatidylcholine and antioxidant enzyme development in the genetically obese Zucker rat.
Topics: Androstanols; Animals; Body Weight; Eating; Glucocorticoids; Lung; Male; Mifepristone; Organ Size; Phospholipids; Rats; Rats, Zucker; Receptors, Glucocorticoid | 1993 |
The effects of the antihormones RU486 and tamoxifen on fetoplacental development and placental bed vascularisation in the rat: a model for intrauterine fetal growth retardation.
Topics: Abortifacient Agents, Steroidal; Animals; Body Weight; Embryo Implantation; Embryonic and Fetal Development; Estrogen Antagonists; Female; Immunohistochemistry; Mifepristone; Placenta; Placentation; Pregnancy; Rats; Rats, Wistar; Tamoxifen | 1996 |
Involvement of type I corticosteroid receptor in the effects of ovariectomy on energy balance.
Topics: Animals; Body Weight; Energy Metabolism; Female; Lipid Metabolism; Mifepristone; Mineralocorticoid Receptor Antagonists; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 1996 |
Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Animals, Newborn; Blood Glucose; Body Weight; Eating; Female; Germ-Free Life; Glucocorticoids; Hormone Antagonists; Hormones; Male; Mifepristone; Obesity; Organ Size; Rats; Rats, Zucker; Reference Values | 1996 |
In vivo antiestrogenic activity of mifepristone in the rat.
Topics: Animals; Body Weight; Corticosterone; Drug Combinations; Estradiol; Estrogen Antagonists; Injections, Subcutaneous; Male; Mifepristone; Organ Size; Pituitary Gland, Anterior; Rats; Rats, Wistar; Tamoxifen | 1997 |
Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Drinking; Eating; Hormone Antagonists; Hyperphagia; Hypothalamus; Insulin; Male; Mifepristone; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Glucocorticoid | 1997 |
Glucocorticoid blockade does not abrogate tumor-induced cachexia.
Topics: Adenocarcinoma; Animals; Body Composition; Body Weight; Cachexia; Colonic Neoplasms; Female; Glucocorticoids; Hormone Antagonists; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mifepristone; Neoplasm Transplantation; Regression Analysis; Tumor Cells, Cultured | 1999 |
Enhanced intestinal synthesis of polyamines from proline in cortisol-treated piglets.
Topics: Animals; Animals, Suckling; Arginine; Biogenic Polyamines; Body Weight; Eating; Enterocytes; Glutamine; Hydrocortisone; Jejunum; Mifepristone; Organ Size; Ornithine; Ornithine Decarboxylase; Proline; Swine | 2000 |
Progestins block cholesterol synthesis to produce meiosis-activating sterols.
Topics: Animals; Body Weight; Cholestadienols; Cholesterol; Estrogen Antagonists; Humans; Hydroxyprogesterones; Male; Meiosis; Miconazole; Mifepristone; Progestins; Rats; Spectrum Analysis; Sterols; Tamoxifen; Testis; Tumor Cells, Cultured | 2001 |
Glucocorticoids and parental hyperphagia in ring doves (Streptopelia risoria).
Topics: Animals; Body Weight; Columbidae; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Eating; Female; Glucocorticoids; Hormone Antagonists; Hyperphagia; Injections, Intramuscular; Injections, Intraventricular; Male; Mifepristone; Nesting Behavior | 2002 |
The epidermis as a bioreactor: topically regulated cutaneous delivery into the circulation.
Topics: Animals; Bioreactors; Body Weight; Epidermis; Feasibility Studies; Gene Expression Regulation; Gene Transfer Techniques; Human Growth Hormone; Humans; Keratinocytes; Mice; Mice, Nude; Mice, Transgenic; Mifepristone; Promoter Regions, Genetic; Receptors, Progesterone | 2002 |
Role of the antiglucocorticoid RU 486 in the prevention of steroid-induced hypertension.
Topics: Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Hypertension; Male; Mifepristone; Rats; Rats, Sprague-Dawley; Reference Values; Sodium Chloride | 1992 |
The progesterone antagonist, RU486 does not affect basal or estrogen-stimulated cancellous bone formation in the rat.
Topics: Animals; Body Weight; Bone Development; Estradiol; Female; Mifepristone; Progesterone; Rats; Rats, Wistar; Tibia | 1992 |
Effects of neonatal exposure to the antiprogestin mifepristone, RU 486, on the sexual development of the rat.
Topics: Animals; Animals, Newborn; Body Weight; Female; Genitalia, Female; Genitalia, Male; Male; Mifepristone; Ovariectomy; Rats; Receptors, Progesterone; Sex Characteristics; Sexual Behavior, Animal; Sexual Maturation | 1992 |
Interactions between oestradiol and the progesterone antagonist RU-486 in establishing and maintaining female rats' sexual responsiveness: central versus peripheral effects.
Topics: Animals; Body Weight; Central Nervous System; Estradiol; Female; Mifepristone; Nociceptors; Organ Size; Ovariectomy; Progesterone; Rats; Rats, Inbred Strains; Sexual Behavior, Animal; Uterus | 1992 |
Protective effects of ciprofloxacin against type II collagen induced arthritis in rats.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Animals; Arthritis; Body Weight; Ciprofloxacin; Collagen; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Interleukin-1; Male; Mifepristone; Monocytes; Rats; Time Factors; Tumor Necrosis Factor-alpha | 1992 |
Reduction of the intake of food and water is responsible for reduction of litter growth when dams are treated with a progesterone antagonist.
Topics: Animals; Animals, Newborn; Body Weight; Drinking; Eating; Female; Gonanes; Lactation; Male; Mifepristone; Milk; Ovariectomy; Pregnancy; Progesterone; Rats; Rats, Inbred Strains | 1991 |
Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice.
Topics: Animals; Body Composition; Body Weight; Drug Administration Schedule; Eating; Female; Fluoxetine; Injections, Subcutaneous; Male; Mice; Mice, Obese; Mifepristone; Obesity; Parenteral Nutrition; Time Factors | 1990 |
Effect of the progesterone antagonist mifepristone on the hypothalamo-hypophysial-ovarian axis in rats.
Topics: 20-alpha-Dihydroprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Bromocriptine; Delayed-Action Preparations; Female; Gonanes; Hypothalamo-Hypophyseal System; Mifepristone; Organ Size; Ovary; Pituitary Gland; Progesterone; Prolactin; Rats; Uterus | 1990 |
Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats.
Topics: Animals; Body Composition; Body Weight; Brain; Corticosterone; Eating; Female; Glucocorticoids; Insulin; Mifepristone; Obesity; Organ Size; Rats; Rats, Zucker | 1990 |
Role of antiglucocorticoid RU 486 on dexamethasone-induced hypertension in rats.
Topics: Animals; Blood Pressure; Body Weight; Dexamethasone; Estrenes; Glucocorticoids; Male; Mifepristone; Rats; Rats, Inbred Strains; Sodium; Thymus Gland | 1989 |
Effects of the antiglucocorticoid RU 486 on adrenal function in dogs.
Topics: Administration, Oral; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Blood Proteins; Body Weight; Dogs; Estrenes; Female; Hematocrit; Hydrocortisone; Mifepristone | 1988 |
Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Animals; Body Weight; Cells, Cultured; Estrenes; Female; Megestrol; Megestrol Acetate; Mifepristone; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid | 1985 |
Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Topics: Animals; Body Weight; Buserelin; Combined Modality Therapy; Estrenes; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mifepristone; Ovariectomy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1987 |
A possible role for endogenous glucocorticoids in orchiectomy-induced atrophy of the rat levator ani muscle: studies with RU 38486, a potent and selective antiglucocorticoid.
Topics: Animals; Atrophy; Body Weight; Dexamethasone; Estrenes; Glucocorticoids; Male; Mifepristone; Muscles; Orchiectomy; Rats; Receptors, Glucocorticoid; Time Factors; Triamcinolone Acetonide | 1986 |